Literature DB >> 22684915

Different inhibitory capacities of human and mouse KLRG1 are linked to distinct disulfide-mediated oligomerizations.

Maike Hofmann1, Oliver Schweier, Hanspeter Pircher.   

Abstract

The killer cell lectin-like receptor G1 (KLRG1) is a cadherin-binding inhibitory receptor expressed by NK and T cells in humans and mice. Although structural and ligand-binding properties of human (h) and mouse (m) KLRG1 are very similar, KLRG1-mediated inhibition under physiological conditions is only observed with human lymphocytes. Using a well-defined in vitro system, we demonstrate here that mKLRG1 exhibits a significantly lower inhibitory capacity compared with the human homolog. Biochemical analyses further showed that mKLRG1 formed monomers and disulfide-linked dimers, trimers, and tetramers whereas hKLRG1 was exclusively present as disulfide-linked dimer. Mutational analysis revealed a crucial role of Cys(62) present in the stalk region of mKLRG1 but not of hKLRG1 for oligomer formation. Strikingly, mimicking hKLRG1 by replacement of Cys(62) in mKLRG1 by glutamine prevented tri- and tetramer formation and increased the inhibitory capacity. Furthermore, mutated mKLRG1 molecules that were unable to form disulfide-linked dimers at all or at a decreased level lacked inhibitory activity. These data indicate that only dimeric KLRG1 entities exhibit potent inhibitory capacities. The lower inhibitory capacity of mKLRG1 compared with hKLRG1 can thus be rationalized by a decreased proportion of dimeric entities, which can be pinpointed to a single amino acid.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22684915     DOI: 10.1002/eji.201142357

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Control of CD8 T cell proliferation and terminal differentiation by active STAT5 and CDKN2A/CDKN2B.

Authors:  Magali Grange; Marilyn Giordano; Amandine Mas; Romain Roncagalli; Guylène Firaguay; Jacques A Nunes; Jacques Ghysdael; Anne-Marie Schmitt-Verhulst; Nathalie Auphan-Anezin
Journal:  Immunology       Date:  2015-06-15       Impact factor: 7.397

2.  Soluble Antigen Arrays Efficiently Deliver Peptides and Arrest Spontaneous Autoimmune Diabetes.

Authors:  Rebuma Firdessa-Fite; Stephanie N Johnson; Martin A Leon; Mohsen Khosravi-Maharlooei; Rocky L Baker; Joshua O Sestak; Cory Berkland; Remi J Creusot
Journal:  Diabetes       Date:  2021-01-19       Impact factor: 9.337

3.  Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation than "Exhaustion" of Human CD8 T Cells.

Authors:  Amandine Legat; Daniel E Speiser; Hanspeter Pircher; Dietmar Zehn; Silvia A Fuertes Marraco
Journal:  Front Immunol       Date:  2013-12-19       Impact factor: 7.561

4.  Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models.

Authors:  Steven A Greenberg; Sek Won Kong; Evan Thompson; Stefano V Gulla
Journal:  Oncotarget       Date:  2019-02-15

5.  A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer.

Authors:  Xi Li; Rouzheng Wang; Peiwen Fan; Xuan Yao; Ling Qin; Yanchun Peng; Miaomiao Ma; Neil Asley; Xuimei Chang; Yaning Feng; Yunhui Hu; Yonghong Zhang; Chris Li; Gregory Fanning; Stephanie Jones; Clare Verrill; David Maldonado-Perez; Paul Sopp; Craig Waugh; Stephen Taylor; Simon Mcgowan; Vincenzo Cerundolo; Christopher Conlon; Andrew McMichael; Shichun Lu; Xiyan Wang; Ning Li; Tao Dong
Journal:  Front Oncol       Date:  2019-10-25       Impact factor: 6.244

6.  A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.

Authors:  Maryam Salimi; Jillian L Barlow; Sean P Saunders; Luzheng Xue; Danuta Gutowska-Owsiak; Xinwen Wang; Li-Chieh Huang; David Johnson; Seth T Scanlon; Andrew N J McKenzie; Padraic G Fallon; Graham S Ogg
Journal:  J Exp Med       Date:  2013-12-09       Impact factor: 14.307

7.  Killer Cell Lectin-like Receptor G1 Inhibits NK Cell Function through Activation of Adenosine 5'-Monophosphate-Activated Protein Kinase.

Authors:  Bojana Müller-Durovic; Alessio Lanna; Luciana Polaco Covre; Rachel S Mills; Sian M Henson; Arne N Akbar
Journal:  J Immunol       Date:  2016-08-26       Impact factor: 5.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.